These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 12939602

  • 21. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, Sung JJ.
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [Abstract] [Full Text] [Related]

  • 22. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
    Suh YJ, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK.
    Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894
    [Abstract] [Full Text] [Related]

  • 23. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS, Kim SH, Song YS, Surh YJ.
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [Abstract] [Full Text] [Related]

  • 24. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1469-78. PubMed ID: 15041464
    [Abstract] [Full Text] [Related]

  • 25. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
    Jendrossek V, Handrick R, Belka C.
    FASEB J; 2003 Aug 15; 17(11):1547-9. PubMed ID: 12824303
    [Abstract] [Full Text] [Related]

  • 26. Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis.
    Yim HW, Jong HS, Kim TY, Choi HH, Kim SG, Song SH, Kim J, Ko SG, Lee JW, Kim TY, Bang YJ.
    Cancer Res; 2005 Mar 01; 65(5):1952-60. PubMed ID: 15753395
    [Abstract] [Full Text] [Related]

  • 27. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.
    Wu T, Leng J, Han C, Demetris AJ.
    Mol Cancer Ther; 2004 Mar 01; 3(3):299-307. PubMed ID: 15026550
    [Abstract] [Full Text] [Related]

  • 28. Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and -3.
    Lai GH, Zhang Z, Sirica AE.
    Mol Cancer Ther; 2003 Mar 01; 2(3):265-71. PubMed ID: 12657721
    [Abstract] [Full Text] [Related]

  • 29. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.
    Fantappiè O, Masini E, Sardi I, Raimondi L, Bani D, Solazzo M, Vannacci A, Mazzanti R.
    Hepatology; 2002 Apr 01; 35(4):843-52. PubMed ID: 11915030
    [Abstract] [Full Text] [Related]

  • 30. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W, Chen Y, Wang W, Keng P, Finkelstein J, Hu D, Liang L, Guo M, Fenton B, Okunieff P, Ding I.
    Am J Clin Oncol; 2003 Aug 01; 26(4):S103-9. PubMed ID: 12902866
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV, Herzog CR, Rao CV.
    Cancer Res; 2003 Sep 01; 63(17):5239-42. PubMed ID: 14500353
    [Abstract] [Full Text] [Related]

  • 32. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
    Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C, Schulze-Bergkamen H, Friess H, Stremmel W, Krammer PH, Schirmacher P, Müller M.
    Cancer Res; 2006 Jul 15; 66(14):7059-66. PubMed ID: 16849551
    [Abstract] [Full Text] [Related]

  • 33. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B, Shi ZL, Feng J, Tao HM.
    Cell Biol Int; 2008 May 15; 32(5):494-501. PubMed ID: 18078766
    [Abstract] [Full Text] [Related]

  • 34. In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice.
    Cui W, Hu SX, Tang ZY, Hu KQ.
    Anticancer Drugs; 2008 Oct 15; 19(9):891-7. PubMed ID: 18766003
    [Abstract] [Full Text] [Related]

  • 35. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.
    Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509
    [Abstract] [Full Text] [Related]

  • 36. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C, Blumenthal RD, Li H, Stein R, Goldenberg DM, Burton J.
    Cancer Res; 2002 Apr 01; 62(7):2029-33. PubMed ID: 11929821
    [Abstract] [Full Text] [Related]

  • 37. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N, Yamazaki R, Kawai S.
    Arthritis Rheum; 2002 Dec 01; 46(12):3159-67. PubMed ID: 12483719
    [Abstract] [Full Text] [Related]

  • 38. 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells.
    Kulp SK, Yang YT, Hung CC, Chen KF, Lai JP, Tseng PH, Fowble JW, Ward PJ, Chen CS.
    Cancer Res; 2004 Feb 15; 64(4):1444-51. PubMed ID: 14973075
    [Abstract] [Full Text] [Related]

  • 39. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
    Cheng J, Imanishi H, Amuro Y, Hada T.
    Int J Cancer; 2002 Jun 10; 99(5):755-61. PubMed ID: 12115513
    [Abstract] [Full Text] [Related]

  • 40. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
    Wu R, Abramson AL, Shikowitz MJ, Dannenberg AJ, Steinberg BM.
    Clin Cancer Res; 2005 Sep 01; 11(17):6155-61. PubMed ID: 16144915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.